Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1617 1632
This examiner grants 26% of resolved cases
David Browe is an examiner in Tech Center 1600 and Art Unit 1617. He has a substantial history of 735 resolved cases, which provides a robust dataset for analyzing his examination style. The allowance rate of 26.4% is relatively low, suggesting a rigorous and challenging examination environment. This 26.4% figure indicates that practitioners must be prepared for a difficult path to securing a patent grant in this docket.
The interview lift of 27.3% is a critical metric for this examiner. This 27.3% figure suggests that while the overall allowance rate is low, conducting an interview significantly increases the probability of success. For practitioners, an interview may be one of the most effective ways to overcome rejections. Furthermore, the median days to allowance is 1427, which serves as a benchmark for the duration of successful prosecution. This 1427-day timeline is an important factor for applicants to consider when planning their strategy in Art Unit 1617. With 735 resolved cases and a 26.4% allowance rate, the data highlights the importance of the 27.3% interview lift in navigating the 1427-day median prosecution cycle.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18300703 | COMPOSITION AND METHODS FOR THE TREATMENT OF PERIPHERAL NERVE INJURY | Non-Final OA | UNIVERSITY OF ROCHESTER |
| 18703132 | SUBSTITUTED BENZAMIDES AS HERBICIDES | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 17576141 | MICRONEEDLE ARRAYS FOR CANCER THERAPY APPLICATIONS | Final Rejection | Carnegie Mellon University |
| 18314808 | COMPOSITION FOR PENETRATING SUGAR BASED DELIVERY SYSTEM | Final Rejection | Evonik Operations GmbH |
| 18642539 | NANOFIBERS AND THEIR USE IN ENHANCING PARTICLE-BASED HYDROGEL SCAFFOLDS FOR REGENERATIVE MEDICINE AND TISSUE ENGINEERING | Non-Final OA | UNIVERSITY OF VIRGINIA PATENT FOUNDATION |
| 18151932 | IMPREGNATED COSMETIC ARTICLE WITH FIBERS AND SCREEN NET | Final Rejection | L'OREAL |
| 18713537 | METHOD FOR TREATING KERATIN SUBSTANCE OR FIBER FOR HEAD DECORATION PRODUCTS | Non-Final OA | KAO CORPORATION |
| 17603995 | A Stable Insecticide Composition | Final Rejection | UPL LTD |
| 17414458 | HERBICIDE | Non-Final OA | UPL LTD |
| 18630721 | IONIZABLE LIPID BASED ON CYCLOHEXANEDIAMINE AND LIPID NANOPARTICLE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | SHANDONG UNIVERSITY |
| 18550432 | METHODS OF DESIGNING AN ORAL DRUG DOSAGE FORM BASED ON A TARGET PK PROFILE AND DOSAGE FORMS THEREOF | Non-Final OA | Triastek, Inc. |
| 17996379 | LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION | Non-Final OA | STATENS SERUM INSTITUT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy